AI-guided exercise and recovery program for people with coronary heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with coronary heart disease who are classified as low exercise risk will be assigned to either an AI-enabled stratified management platform used with a sports wristband or to routine post-discharge care and followed for three months. The AI platform provides personalized exercise prescriptions, remote monitoring via the wristband, motivational support, and tailored risk-factor management through a smartphone app. The primary outcome is change in peak oxygen consumption (VO2peak) at 3 months, with secondary outcomes including daily physical activity, exercise adherence and motivation, control of modifiable cardiovascular risk factors, and safety of home-based exercise. Baseline and follow-up visits occur at Fuwai Hospital with ongoing remote data collection through the app and wearable.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* CHD patients aged over 18 years;
* Stratified as low-risk for cardiovascular events during exercise and classified as low-risk according to the GRACE risk score.
* Ability of the patient or close relatives to use smartphones and applications;
* Willingness to participate and sign the informed consent form.

Exclusion Criteria:

* Residual stenosis of \>50% in the left main coronary artery, or \>70% stenosis in other major epicardial vessels;
* Planned coronary revascularization within the next 3 months;
* Acute myocardial infarction within the past 1 month;
* Severe cognitive impairment;
* Severely impaired exercise capacity.
* Advanced-stage malignancy;
* Life expectancy less than 3 months;
* Severe multi-organ failure;
* Other conditions deemed unsuitable for home-based exercise rehabilitation following assessment by a specialist rehabilitation physician.
* Refusal to provide written informed consent.

Where it's running

• Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Prof. Gao, MD, PhD
• Email: sophie_gao@sina.com
• Phone: 010-88322413

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• eCardiacRehab: a home-based, patient-centered cardiac rehab program

  This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.

  Recruiting Haukeland University Hospital · Bergen · NCT07590635

• Conscious Sedation vs General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation

  This trial tests whether local anesthesia with conscious sedation can match general anesthesia for pulsed field ablation in adults with paroxysmal atrial fibrillation.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07877519

• Biomarkers to predict CSA-AKI risk before heart surgery

  This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07811570

• Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock

  This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07769528

• QFR-Guided Heart Revascularization Quality Registry in CAD

  This registry tests whether using quantitative flow ratio (QFR) to guide coronary revascularization decisions across many centers can standardize quality in patients with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07766434

• Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI

  This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07749417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.